Kozak & Associates’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$482 Hold
36
﹤0.01% 401
2026
Q1
$303 Buy
36
+1
+3% +$8 ﹤0.01% 416
2025
Q4
$285 Hold
35
﹤0.01% 405
2025
Q3
$270 Hold
35
﹤0.01% 427
2025
Q2
$349 Hold
35
﹤0.01% 389
2025
Q1
$398 Hold
35
﹤0.01% 402
2024
Q4
$534 Buy
35
+1
+3% +$16 ﹤0.01% 390
2024
Q3
$609 Buy
34
+1
+3% +$21 ﹤0.01% 359
2024
Q2
$680 Hold
33
﹤0.01% 350
2024
Q1
$711 Sell
33
-49
-60% -$841 ﹤0.01% 354
2023
Q4
$1.35K Sell
82
-16
-16% -$218 ﹤0.01% 332
2023
Q3
$1.63K Sell
98
-4
-4% -$83 ﹤0.01% 342
2023
Q2
$2.1K Buy
102
+1
+1% +$22 ﹤0.01% 304
2023
Q1
$2.37K Buy
101
+15
+17% +$403 ﹤0.01% 297
2022
Q4
$2K Buy
86
+1
+1% +$26 ﹤0.01% 309
2022
Q3
$2K Buy
85
+1
+1% +$30 ﹤0.01% 303
2022
Q2
$3K Sell
84
-254
-75% -$8.9K ﹤0.01% 326
2022
Q1
$12K Hold
338
0.01% 239
2021
Q4
$12K Buy
338
+2
+0.6% +$65 0.01% 239
2021
Q3
$11K Buy
+336
New +$10.8K 0.01% 235

Other funds holding OGN

Kozak & Associates's OGN Position: Q2 2026 in Review

Kozak & Associates held its Organon & Co (OGN) position steady in Q2 2026 at 36 shares worth $482. The position accounts for ﹤0.01% of the portfolio, ranked #401.

Kozak & Associates first reported a position in OGN in Q3 2021 and has held it in 20 quarters since. The position peaked at $12K in Q1 2022. 107 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Kozak & Associates held 36 shares of Organon & Co worth $482 as of Q2 2026.
  • Kozak & Associates left its Organon & Co share count unchanged in Q2 2026.
  • Organon & Co made up ﹤0.01% of Kozak & Associates's portfolio in Q2 2026, its #401 holding.
  • Kozak & Associates first reported a position in Organon & Co in Q3 2021 and has held it in 20 quarters since.
  • Kozak & Associates's Organon & Co position peaked at $12K in Q1 2022.
  • 107 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Kozak & Associates's 13F filing for Q2 2026, filed 2 Jul 2026.